Skip to main content
logo
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.85
+0.74 (10.41%)
At close: Aug 14, 2026, 4:00 PM EDT
7.58
-0.27 (-3.44%)
After-hours: Aug 14, 2026, 7:48 PM EDT

Aspire Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
12.17100.010
Cash & Short-Term Investments
12.17100.010
Cash Growth
5799.70%27532.92%-67.49%29305.26%-
Inventory
0.290.25---
Prepaid Expenses
1.010.060.140.040.02
Total Current Assets
13.471.310.150.050.02
Total Assets
13.541.310.150.050.02

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
0.971.010.310.170.12
Accrued Expenses
0.711.36---
Short-Term Debt
-5.181.270.360.03
Other Current Liabilities
-0.040.1100
Total Current Liabilities
1.697.591.690.530.15
Other Long-Term Liabilities
0.10.1--0
Total Liabilities
1.787.691.690.530.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
0000.020.22
Additional Paid-In Capital
43.5120.881.240.960.76
Retained Earnings
-31.75-27.26-2.78-1.47-1.11
Shareholders' Equity
11.76-6.38-1.54-0.49-0.13
Total Liabilities & Equity
13.541.310.150.050.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
-5.181.270.360.03
Net Cash (Debt)
12.17-4.17-1.26-0.35-0.03
Net Cash Growth
-----
Net Cash Per Share
36.71-83.71-54.93-0.00-
Filing Date Shares Outstanding
1.40.17440443.32-
Total Common Shares Outstanding
1.30.12440443-
Working Capital
11.78-6.28-1.54-0.49-0.13
Book Value Per Share
9.08-54.14-0.00-0.00-
Tangible Book Value
11.76-6.38-1.54-0.49-0.13
Tangible Book Value Per Share
9.08-54.14-0.00-0.00-
SEC Filings: 10-K · 10-Q